These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17250731)

  • 21. Isokinetic assessment of the effects of botulinum toxin injection on spasticity and voluntary strength in patients with spastic hemiparesis.
    Hameau S; Bensmail D; Robertson J; Boudarham J; Roche N; Zory R
    Eur J Phys Rehabil Med; 2014 Oct; 50(5):515-23. PubMed ID: 24651151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin A in the treatment of spasticity: functional implications and patient selection.
    Pierson SH; Katz DI; Tarsy D
    Arch Phys Med Rehabil; 1996 Jul; 77(7):717-21. PubMed ID: 8670002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin for treatment of spasticity in adults.
    Reichel G
    J Neurol; 2001 Apr; 248 Suppl 1():25-7. PubMed ID: 11357235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does calf muscle spasticity contribute to postural imbalance? A study in persons with pure hereditary spastic paraparesis.
    de Niet M; Weerdesteyn V; de Bot ST; van de Warrenburg BP; Geurts AC
    Gait Posture; 2013 Jun; 38(2):304-9. PubMed ID: 23433545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upper extremity function and occupational performance in children with spastic cerebral palsy following lower extremity botulinum toxin injections.
    Keren-Capelovitch T; Jarus T; Fattal-Valevski A
    J Child Neurol; 2010 Jun; 25(6):694-700. PubMed ID: 20508235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there evidence that botulinum toxin injections are more effective than phenol injections in relieving poststroke reflex activity during plantar flexion, thereby increasing ankle range of motion and improving gait function?
    Cormack J; Powers CM
    Phys Ther; 2004 Jan; 84(1):76-84. PubMed ID: 14992678
    [No Abstract]   [Full Text] [Related]  

  • 27. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.
    Simpson DM; Alexander DN; O'Brien CF; Tagliati M; Aswad AS; Leon JM; Gibson J; Mordaunt JM; Monaghan EP
    Neurology; 1996 May; 46(5):1306-10. PubMed ID: 8628472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of spasticity in adults: practical application of botulinum toxin.
    Pathak MS; Nguyen HT; Graham HK; Moore AP
    Eur J Neurol; 2006 Feb; 13 Suppl 1():42-50. PubMed ID: 16417597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: analysis of function and kinematics of reaching movements.
    Bensmail D; Robertson JV; Fermanian C; Roby-Brami A
    Neurorehabil Neural Repair; 2010; 24(3):273-81. PubMed ID: 20067949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke.
    Reiter F; Danni M; Lagalla G; Ceravolo G; Provinciali L
    Arch Phys Med Rehabil; 1998 May; 79(5):532-5. PubMed ID: 9596394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional and clinical changes in upper limb spastic patients treated with botulinum toxin (BTX).
    Panizza M; Castagna M; di Summa A; Saibene L; Grioni G; Nilsson J
    Funct Neurol; 2000; 15(3):147-55. PubMed ID: 11062843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients.
    Hesse S; Jahnke MT; Luecke D; Mauritz KH
    Neurosci Lett; 1995 Dec; 201(1):37-40. PubMed ID: 8830307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose botulinum toxin with short-term electrical stimulation in poststroke spastic drop foot: a preliminary study.
    Bayram S; Sivrioglu K; Karli N; Ozcan O
    Am J Phys Med Rehabil; 2006 Jan; 85(1):75-81. PubMed ID: 16357552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meaningful improvement in walking performance after Botulinum neurotoxin A (BoNT-A) in chronic spastic patients.
    Cioncoloni D; Taddei S; Bielli S; Annunziata P; Mazzocchio R
    NeuroRehabilitation; 2014; 34(1):185-92. PubMed ID: 24284465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intrathecal baclofen in hereditary spastic paraparesis: benefits and limitations].
    Lambrecq V; Muller F; Joseph PA; Cuny E; Mazaux JM; Barat M
    Ann Readapt Med Phys; 2007 Oct; 50(7):577-81. PubMed ID: 17368612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: grasp strategies and kinematics of reach-to-grasp movements.
    Bensmail D; Robertson J; Fermanian C; Roby-Brami A
    Neurorehabil Neural Repair; 2010 Feb; 24(2):141-51. PubMed ID: 19786722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing soleus injections and gastrocnemius injections of botulinum toxin for treating adult spastic foot drop: a monocentric observational study.
    Hefter H; Nickels W; Samadzadeh S; Rosenthal D
    J Int Med Res; 2021 Mar; 49(3):300060521998208. PubMed ID: 33784844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients.
    Hesse S; Lücke D; Malezic M; Bertelt C; Friedrich H; Gregoric M; Mauritz KH
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1321-4. PubMed ID: 7964805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gait analysis of sporadic and hereditary spastic paraplegia.
    Klebe S; Stolze H; Kopper F; Lorenz D; Wenzelburger R; Volkmann J; Porschke H; Deuschl G
    J Neurol; 2004 May; 251(5):571-8. PubMed ID: 15164190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.